OTC:INTI | Operating Income | Inhibitor Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2012-09-30 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$618,597.00
2026-03-31-$695,632.00
2025-12-31-$1.32M
2025-09-30-$741,215.00
2025-06-30-$695,773.00
2025-03-31-$674,551.00
2024-12-31-$1.48M
2024-09-30-$813,196.00
2024-06-30-$585,147.00
2024-03-31-$774,817.00
2023-12-31-$1.27M
2023-09-30-$759,528.00
2023-06-30-$742,461.00
2023-03-31-$629,724.00
2022-12-31-$423,635.00
2022-09-30-$69,987.00
2022-06-30-$70,804.00
2022-03-31-$93,500.00
2021-12-31-$28,759.00
2021-09-30-$66,248.00
2021-06-30-$62,635.00
2021-03-31-$167,753.00
2020-12-31-$55,727.00
2020-09-30-$302,774.00
2020-06-30-$315,044.00
2020-03-31-$385,442.00
2019-12-31-$637,875.00
2019-09-30-$682,921.00
2019-06-30-$635,500.00
2019-03-31-$791,600.00
2018-12-31-$1.33M
2018-09-30-$1.18M
2018-06-30-$884,406.00
2018-03-31-$1.17M
2017-12-31-$905,357.00
2017-09-30-$681,166.00
2017-06-30-$719,436.00
2017-03-31-$2.81M
2016-12-31-$2.76M
2016-09-30-$1.73M
2016-06-30-$1.33M
2016-03-31-$1.19M
2015-12-31-$1.03M
2015-09-30-$1.2M
2015-06-30-$791,656.00
2015-03-31-$922,674.00
2014-12-31-$897,133.00
2014-09-30-$738,090.00
2014-06-30-$2.12M
2014-03-31-$186,930.00
2013-12-31-$213,246.00
2013-09-30-$1.29M
2013-06-30-$403,580.00
2013-03-31-$90,545.00
2012-12-31-$206,744.00
2012-09-30-$137,469.00

Annual Operating Income

DateOperating Income
2025-12-31-$3.43M
2024-12-31-$3.66M
2023-12-31-$3.4M
2022-12-31-$657,926.00
2021-12-31-$325,395.00
2020-12-31-$1.06M
2019-12-31-$2.75M
2018-12-31-$4.56M
2017-12-31-$5.12M
2016-12-31-$7.02M
2015-12-31-$3.95M
2014-12-31-$3.94M
2013-12-31-$2M
2012-12-31-$560,670.00